MATTB provides assistance and training through outreach to industry. A: CDER's Division of Drug Information (DDI) serves as a focal point for public inquiries regarding human drug products.

Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that ...

One of the most vocal objections came from Dr. Ellis Unger, who was director of the Office of Drug Evaluation at CDER. According to Unger, Woodcock was intensely involved in the review of Exondys ...

director of the FDA's Center for Drug Evaluation and Research (CDER). "Based on our review of available data, and consistent with the advice of the advisory committee, we are taking this next step ...

M.D., director of the Office of Nonprescription Drug Products in CDER, said in the release. “Consumers can also talk to their doctor or pharmacist about ways to treat these symptoms.” ...

Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research (CDER), emphasized that the agency's role is to ensure drugs are both safe and effective. She noted that ...

and what specific improvements in speed and accuracy the FDA has observed so far? CDER, in collaboration with the Center for Biologics Evaluation and Research (CBER) and the Center for Devices and ...

This program is modeled after the Center for Drug Evaluation and Research (CDER) drug trials snapshots program. The snapshots address questions about who participated in clinical studies of new ...

7, 107–109; 2008) — the FDA has been actively recruiting new employees, and CDER achieved a net gain of 396 staff in FY 2008 with 121 specifically working in the OND. “It's very good news ...

During his December 2009 presentation to the FDA–CMS (Centers for Medicare and Medicaid Services) summit, John Jenkins, Director of the Office of New Drugs at CDER, noted that “Incorporating ...

CDER Director Patrizia Cavazzoni and CBER Director Peter Marks provided an update on the rare disease innovation hub in a new FDA Voices blog post. FDA’s Patrizia Cavazzoni, director, Center for Drug ...